Showing results (2031-2040 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 1, 1996
Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-alpha-2a in patients with advanced malignanciesS Wadler, H Haynes, R Schechner, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreasR M Scher, R Kosierowski, C Lusch, et al.
Investigational New Drugs|April 22, 2008
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemiaWendy Stock, Samir D Undevia, Carol Bivins, et al.
Investigational New Drugs|April 2, 2008
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?Andrew H Ko, Elizabeth Dito, Brian Schillinger, et al.
Investigational New Drugs|April 27, 2025
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activityArun A Azad, Howard Gurney, Craig Underhill, et al.
Investigational New Drugs|April 15, 2025
Patient-derived tumor organoids for cancer immunotherapy: culture techniques and clinical applicationNingning Yao, Na Jing, Jianzhong Lin, et al.
Investigational New Drugs|June 13, 2025
Research progress on cancer-related epigenetic switchesChunyu Yu, Jie Sun, Jinlong Tong, et al.
Investigational New Drugs|May 31, 2025
Efficacy and safety of orelabrutinib combined with rituximab and high dose methotrexate in primary or secondary central nervous system diffuse large B-cell lymphoma: a retrospective analysisJiahao Zhou, Lingxiao Xing, Yi Miao, et al.
Investigational New Drugs|June 4, 2025
Approval of high-benefit oncology drugs in Japan: utilization of expedited regulatory pathways for the accelerated approved anticancer drugsAyumi Taguchi, Naoki Matsumaru, Katsura Tsukamoto
Investigational New Drugs|May 19, 2025
Medulloblastoma associated with Lynch syndrome: a case report of germline MLH1 variant and tumor molecular characterizationHan Zheng, Gang Zhang, Bin Jiang, et al.
Pageof 372